U.S. researchers have developed a fusion protein that is able to block the spread of some cancer cells by preventing the cells from ingesting a vital protein called methionine, without damaging normal cells. It could be particularly helpful in cases of breast, lung, prostate and pancreatic cancers.

Related Summaries